GlassScriptPhysician profile
Tiffany Lanette Epps
NPI 1053664912
$3,560.60
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $659 · 2022: $1,120 · 2023: $1,695 · 2024: $86.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200 · Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
| Food and Beverage | $582.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,565.12 | 2021-2023 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals LP | $189.18 | 2022-2023 | Enhertu, Lynparza |
| Clovis Oncology, INC. | $185.68 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $124.99 | 2023 | Pyrukynd |
| Genzyme Corporation | $102.15 | 2023 | |
| Phathom Pharmaceuticals, INC. | $86.77 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $85.20 | 2022-2023 | Ninlaro, Iclusig |
| Seagen INC. | $69.80 | 2022 | |
| Myriad Genetic Laboratories, INC. | $43.56 | 2022 | |
| Amgen INC. | $33.07 | 2023 | Prolia, Evenity |
| Celgene Corporation | $23.93 | 2021 | |
| Tactile Systems Technology INC | $20.00 | 2021 | |
| Merck Sharp & Dohme LLC | $19.93 | 2021 | |
| Eisai INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Epps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.